Arcellx (ACLX) Treasury Shares (2021 - 2025)
Arcellx (ACLX) recorded quarterly Treasury Shares of $2.1 million in Q4 2025, up 15.86% quarter-over-quarter from $1.8 million in Q4 2024, and up 15.86% on a YoY basis from $1.8 million in Q4 2024.
Arcellx (ACLX) Treasury Shares (2021 - 2025) Analysis & Trends
Arcellx's Treasury Shares history runs 5 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- In Q4 2025, Treasury Shares rose 15.86% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (up 15.86% YoY), while the FY2025 annual figure was $2.1 million, up 15.86% from the prior year.
- Treasury Shares was $2.1 million for Q4 2025 at Arcellx, up from $1.8 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $6.3 million in Q1 2022 to a low of $495000.0 in Q2 2023.
- Historically, Treasury Shares has averaged $1.7 million across 5 years, with a median of $1.4 million in 2023.
- Biggest YoY gain for Treasury Shares was 48.66% in 2023; the steepest drop was 76.96% in 2023.
- A 5-year view of Treasury Shares shows it stood at $952804.0 in 2021, then changed by 0.0% to $952804.0 in 2022, then soared by 48.66% to $1.4 million in 2023, then grew by 27.91% to $1.8 million in 2024, then climbed by 15.86% to $2.1 million in 2025.
- The last three Treasury Shares figures came in at $2.1 million (Q4 2025), $1.8 million (Q4 2024), and $1.4 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 495,000.00 |
| Jun 30, 2023 | 495,000.00 |
| Mar 31, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 952,804.00 |
| Dec 31, 2022 | 952,804.00 |
| Sep 30, 2022 | 952,804.00 |
| Sep 30, 2022 | 952,804.00 |
| Jun 30, 2022 | 828,404.00 |
| Jun 30, 2022 | 828,404.00 |
| Mar 31, 2022 | 6.27 Mn |
| Mar 31, 2022 | 6.27 Mn |